NL174144C - 6,7-dialkoxy-4-piperidinochinazolinen, alsmede werkwijze ter bereiding van dergelijke verbindingen en farmaceutische preparaten, die deze verbindingen bevatten. - Google Patents

6,7-dialkoxy-4-piperidinochinazolinen, alsmede werkwijze ter bereiding van dergelijke verbindingen en farmaceutische preparaten, die deze verbindingen bevatten.

Info

Publication number
NL174144C
NL174144C NLAANVRAGE7810865,A NL7810865A NL174144C NL 174144 C NL174144 C NL 174144C NL 7810865 A NL7810865 A NL 7810865A NL 174144 C NL174144 C NL 174144C
Authority
NL
Netherlands
Prior art keywords
compounds
piperidinoquinazolines
dialkoxy
preparing
pharmaceutical preparations
Prior art date
Application number
NLAANVRAGE7810865,A
Other languages
English (en)
Dutch (nl)
Other versions
NL7810865A (nl
NL174144B (nl
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NL7810865A publication Critical patent/NL7810865A/xx
Publication of NL174144B publication Critical patent/NL174144B/xx
Application granted granted Critical
Publication of NL174144C publication Critical patent/NL174144C/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/40—Acylated substituent nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
    • C07D211/28—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms to which a second hetero atom is attached
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/42—Radicals substituted by singly-bound nitrogen atoms having hetero atoms attached to the substituent nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
NLAANVRAGE7810865,A 1977-11-03 1978-11-01 6,7-dialkoxy-4-piperidinochinazolinen, alsmede werkwijze ter bereiding van dergelijke verbindingen en farmaceutische preparaten, die deze verbindingen bevatten. NL174144C (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4566977 1977-11-03

Publications (3)

Publication Number Publication Date
NL7810865A NL7810865A (nl) 1979-05-07
NL174144B NL174144B (nl) 1983-12-01
NL174144C true NL174144C (nl) 1984-05-01

Family

ID=10438111

Family Applications (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE7810865,A NL174144C (nl) 1977-11-03 1978-11-01 6,7-dialkoxy-4-piperidinochinazolinen, alsmede werkwijze ter bereiding van dergelijke verbindingen en farmaceutische preparaten, die deze verbindingen bevatten.

Country Status (24)

Country Link
US (1) US4188391A (de)
JP (1) JPS5498786A (de)
AR (2) AR221851A1 (de)
AT (1) AT366043B (de)
AU (1) AU506317B2 (de)
BE (1) BE871769A (de)
CA (1) CA1086735A (de)
CH (1) CH637130A5 (de)
DE (1) DE2847622A1 (de)
DK (1) DK488078A (de)
ES (2) ES474763A1 (de)
FI (1) FI63934C (de)
FR (1) FR2407926A1 (de)
HK (1) HK94184A (de)
IE (1) IE47996B1 (de)
IL (1) IL55845A (de)
IT (1) IT1101287B (de)
KE (1) KE3351A (de)
LU (1) LU80461A1 (de)
MY (1) MY8500284A (de)
NL (1) NL174144C (de)
PH (1) PH14693A (de)
PT (1) PT68733A (de)
SE (1) SE7811323L (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4489075A (en) * 1982-05-15 1984-12-18 Pfizer Inc. Cyclic sulfonamidoalkyl substituted 4-piperidinoquinazoline cardiac stimulants
JPS61215389A (ja) * 1985-03-20 1986-09-25 Kyowa Hakko Kogyo Co Ltd キナゾリン誘導体およびそれを含有する強心剤
US5614627A (en) * 1993-09-10 1997-03-25 Eisai Co., Ltd. Quinazoline compounds
ZA977103B (en) * 1996-08-09 1999-02-08 Eisai Co Ltd Benzopiperidine derivatives
JP2009506069A (ja) 2005-08-26 2009-02-12 ブレインセルス,インコーポレイティド ムスカリン性受容体調節による神経発生
EP2258359A3 (de) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenese durch Modulation des Muscarinrezeptors mit Sabcomelin
US7985756B2 (en) 2005-10-21 2011-07-26 Braincells Inc. Modulation of neurogenesis by PDE inhibition
WO2007053596A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) * 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
CA2643199A1 (en) * 2006-03-08 2007-09-13 Braincells, Inc. Modulation of neurogenesis by nootropic agents
WO2007134077A2 (en) 2006-05-09 2007-11-22 Braincells, Inc. 5 ht receptor mediated neurogenesis
US20100009983A1 (en) * 2006-05-09 2010-01-14 Braincells, Inc. 5 ht receptor mediated neurogenesis
WO2007134136A2 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
EP2068872A1 (de) * 2006-09-08 2009-06-17 Braincells, Inc. Kombinationen mit einem 4-acylaminopyridin-derivat
EP2066355A2 (de) * 2006-09-19 2009-06-10 Braincells, Inc. Kombination aus einem durch einen peroxisom-proliferator aktivierten rezeptor-mittel und einem zweiten neurogenen mittel zur behandlung von erkrankungen des nervensystems sowie zur förderung von neuraler differenzierung und neurogenese
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
KR20090061029A (ko) * 2006-10-06 2009-06-15 보오슈 앤드 롬 인코포레이팃드 퀴놀론 카르복실산, 그의 유도체, 그의 제조 방법 및 항박테리아제로서의 그의 용도
US7632944B2 (en) * 2007-01-24 2009-12-15 Bausch & Lomb Incorporated Quinolone carboxylic acids, derivatives thereof, and methods of making and using same
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
EP2804603A1 (de) 2012-01-10 2014-11-26 President and Fellows of Harvard College Betazellen-replikation für promoterverbindungen und verwendungsverfahren dafür
US11407729B2 (en) * 2019-03-19 2022-08-09 Stingray Therapeutics, Inc. Quinoline and quinazoline compounds and methods of use thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3812127A (en) * 1966-10-31 1974-05-21 Pfizer 4-(quinolin-4-yl)piperazine-1-carboxylic acid esters
GB1199768A (en) * 1966-10-31 1970-07-22 Pfizer & Co C Nitrogen Heterocycles and process for their preparation
US3517005A (en) * 1967-10-26 1970-06-23 Pfizer & Co C Certain 2- and 4-substituted quinazolines
GB1460389A (en) * 1974-07-25 1977-01-06 Pfizer Ltd 4-substituted quinazoline cardiac stimulants

Also Published As

Publication number Publication date
IL55845A0 (en) 1979-01-31
IT7829368A0 (it) 1978-11-02
FI63934B (fi) 1983-05-31
AU4127778A (en) 1979-05-17
NL7810865A (nl) 1979-05-07
AR221251A1 (es) 1981-01-15
SE7811323L (sv) 1979-05-04
AT366043B (de) 1982-03-10
MY8500284A (en) 1985-12-31
DE2847622A1 (de) 1979-05-31
BE871769A (fr) 1979-05-03
ES474763A1 (es) 1980-12-16
JPS566428B2 (de) 1981-02-10
AR221851A1 (es) 1981-03-31
NL174144B (nl) 1983-12-01
PH14693A (en) 1981-11-10
ATA783878A (de) 1981-07-15
ES480053A1 (es) 1980-07-16
IL55845A (en) 1982-07-30
US4188391A (en) 1980-02-12
FR2407926B1 (de) 1982-11-12
CA1086735A (en) 1980-09-30
LU80461A1 (fr) 1980-05-07
PT68733A (en) 1978-12-01
FR2407926A1 (fr) 1979-06-01
HK94184A (en) 1984-12-07
FI783325A7 (fi) 1979-05-04
FI63934C (fi) 1983-09-12
AU506317B2 (en) 1979-12-20
IT1101287B (it) 1985-09-28
IE47996B1 (en) 1984-08-22
DK488078A (da) 1979-05-04
CH637130A5 (de) 1983-07-15
JPS5498786A (en) 1979-08-03
KE3351A (en) 1983-12-16

Similar Documents

Publication Publication Date Title
NL7800363A (nl) Nieuwe 4.9-dieen-11b-gesubstitueerde steroid- derivaten, werkwijze ter bereiding daarvan en farmaceutische preparaten, die deze steroid- derivaten bevatten.
NL7800824A (nl) Insecticideverbindingen, preparaten die deze bevatten, alsmede werkwijzen ter bereiding daarvan.
NL7711042A (nl) Fenoxy-amino-propanolen en werkwijze ter berei- ding daarvan alsmede werkwijzen ter bereiding van farmaceutische preparaten die deze verbin- dingen bevatten.
NL174144B (nl) 6,7-dialkoxy-4-piperidinochinazolinen, alsmede werkwijze ter bereiding van dergelijke verbindingen en farmaceutische preparaten, die deze verbindingen bevatten.
NL7809092A (nl) 1-fenyl 2-azolyl-4,4-dimethyl-1-penteen-3-ol derivaten, werkwijze ter bereiding van deze verbindingen en fungi- cide preparaten die zo'n verbinding bevatten.
NL7607533A (nl) Werkwijze ter bereiding van een geneesmiddel, zo gevormd geneesmiddel en werkwijze ter be- reiding van actieve verbindingen.
NL7703133A (nl) Werkwijze ter bereiding van nieuwe gesubstitu- eerde fluoracylresorcinolen en van farmaceu- tische, cosmetische en pesticide preparaten, die deze fluoracylresorcinolen bevatten.
NL8300934A (nl) Gesubstitueerde 1h-pyrazolo1,5-a-pyrimidinen, werkwijzen ter bereiding ervan, alsmede farmaceutische preparaten, die deze verbindingen bevatten.
NL7712559A (nl) Piperidinederivaten, werkwijzen ter bereiding daarvan en farmaceutische preparaten die deze verbindingen bevatten.
NL7803083A (nl) Nieuwe morfinederivaten, werkwijzen ter berei- ding van deze verbindingen alsmede farmaceu- tische preparaten die een dergelijke verbinding bevatten.
NL7714066A (nl) 1.4-dihydropyridineverbindingen, werkwijze voor de bereiding daarvan en farmaceutische prepara- ten, die deze verbindingen bevatten.
NL7704566A (nl) Werkwijze ter bereiding van nieuwe 1,2-dihydro- naftaleenderivaten, alsmede werkwijze ter bereiding van farmaceutische preparaten.
NL7804345A (nl) Imidazoazinen en imidazodiazinen, werkwijze ter berei- ding daarvan en farmaceutische preparaten.
NL7614567A (nl) Werkwijze ter bereiding van een geneesmiddel en werkwijze ter bereiding van de geneeskrachtige verbinding.
NL7902700A (nl) 2-(2-thenoylthio)-propionylglycine, werkwijze ter be- reiding ervan alsmede farmaceutische preparaten, die deze verbinding bevatten.
NL7803623A (nl) N-acetyl-dehydro-thienamycine en zouten daarvan; werk- wijze ter bereiding van deze verbindingen en farmaceu- tische preparaten.
NL190115C (nl) Amine, dat een alfa-ethynylgroep bevat, werkwijze ter bereiding van een zodanig amine, alsmede een farmaceutisch preparaat, dat zo'n amine bevat.
NL187167C (nl) Werkwijze ter bereiding van gona-4,9(10)-dienen, werkwijze ter bereiding van geneesmiddelen die deze verbindingen bevatten, alsmede gevormde geneesmiddelen.
NL7708306A (nl) 2-benzylpyrrolidinen, werkwijzen ter bereiding daarvan en geneesmiddelen, die deze verbin- dingen bevatten.
NL7902449A (nl) 3-0-(beta-d-glucuronopyranosyl)-sojasapogenol b en zouten daarvan, farmaceutische preparaten die deze verbindingen bevatten alsmede werkwijzen voor de berei- ding van de genoemde verbindingen.
NL7901818A (nl) Nieuwe bicyclo-octaanderivaten, werkwijze ter bereiding van deze verbindingen, alsmede farmaceutische prepara- ten die zo'n verbinding bevatten.
NL7811786A (nl) Gesubstitueerde pyrrolidinen, werkwijze ter bereiding van deze verbindingen en geneesmiddelen die deze ver- bindingen bevatten.
NL7803084A (nl) Nieuwe morfinederivaten, werkwijzen ter berei- ding van deze verbindingen alsmede farmaceu- tische preparaten die een dergelijke verbinding bevatten.
NL185920C (nl) Werkwijze ter bereiding van 2'6'-dialkyl-n-(alkoxymethyl)-2-chlooraceetaniliden en fytotoxische preparaten die deze verbindingen bevatten.
NL7802380A (nl) Benzylpyrimidinen, een werkwijze voor de berei- ding daarvan en farmaceutische preparaten die deze verbindingen bevatten.

Legal Events

Date Code Title Description
A1A A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
V1 Lapsed because of non-payment of the annual fee